Volume 15, Number 11—November 2009
Imported Human Fascioliasis, United Kingdom
|Case no.||Age, y/sex||Country of origin||Years since migration||Other travel||Risk factor||Clinical features||Eosinophil count, x109/L)||Abnormal liver function||Hepatic imaging||IFAT†|
|1||45/F||Yemen||7||Yemen regularly||Khat use||Abdominal pain||8.4||Yes||Mixed-density liver lesion (CT)||1:128|
|2||44/M||Somalia||16||Ethiopia 2007||Khat use||Fever, abdominal pain||3.4||Yes||Serpiginous lesion (MRI)||1:64|
|3||34/F||Ethiopia||3||S. Africa regularly||Khat use||Fever, abdominal pain||11.4||No||Heterogeneous lesion (USS)||1:128|
|4||44/F||Somalia||7||Somalia 2004, Netherlands||Khat use||Abdominal pain||8.3||No||Heterogeneous lesion (USS)||1:128|
|5||54/F||Somalia||21 (to Netherlands), 4 (to UK)||None||Khat use||Anorexia||8.4||No||Low-density lesion (CT)||1:32|
|6||43/M||Somalia||28 (to India), 21 (to UK)||None||Khat use||Fever||1.0||Yes||Heterogeneous lesion (USS)||1:128|
|7||28/F||UK||–||Uganda 2007–2008||–||Abdominal pain, hepatomegaly||1.84||Yes||Hepatomegaly with large mixed cystic and solid lesion (USS)||1:512|
|8||67/M||UK||–||Kenya 2008, prior world travel||–||Malaise, abdominal pain||0.04||Yes||Multiple gallstones (MRCP)||1:256|
|9||38/M||Ethiopia||10||Ethiopia 2006||–||Abdominal pain, fever||18.7||Yes||Normal (USS, MRCP)||1:128|
|10||28/M||Ethiopia||Unknown||Unknown||–||Fever, gram- negative sepsis; new HIV diagnosis||<0.04||Yes||Lesion in hepatic vein||1:64|
|11||47/F||Somalia||16 (to Yemen), 6 (to UK)||Unknown||Khat use||Abdominal pain, fever||16.8||Yes||Low-density lesion (CT)||1:256|
*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic resonance cholangiopancreatography.
†Titer of IFAT (screening titer 32).
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.